bioAffinity Technologies ...

AI Score

0

Unlock

0.50
-0.00 (-0.30%)
At close: Jan 15, 2025, 12:19 PM
undefined%
Bid 0.5
Market Cap 7.82M
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) 0
PE Ratio (ttm) n/a
Forward PE n/a
Analyst n/a
Ask 0.5
Volume 1,369
Avg. Volume (20D) 0
Open 0.50
Previous Close 0.50
Day's Range 0.50 - 0.50
52-Week Range 0.50 - 0.50
Beta undefined

About BIAFW

bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX....

Sector Healthcare
IPO Date n/a
Employees 75
Stock Exchange NASDAQ
Ticker Symbol BIAFW
No News article available yet